ORGANISMS AND ANTIMICROBIAL QUICK GUIDE (GRAM-POSITIVE ORGANISMS)
ORGANISMS AND ANTIMICROBIAL QUICK GUIDE (GRAM-POSITIVE ORGANISMS)
In this topic:
1.1 Staphylococcus aureus or Methicillin Sensitive Staphylococcus aureus (MSSA)
Preferred
IV: Cloxacillin, Cefazolin
PO: Cephalexin, Cloxacillin
Alternative
--
Comments
Methicillin (oxacillin)-susceptible staphylococci can be considered susceptible to:
Beta-lactam combination agents (amoxicillin-clavulanate, ampicillin-sulbactam, piperacillin-tazobactam)
Oral cephalosporins (cephalexin, cefuroxime)
Parenteral cephalosporins (cefazolin, cefuroxime, cefoperazone, cefotaxime, ceftriaxone, cefepime, ceftaroline)
Carbapenems (ertapenem, imipenem, meropenem)
1.2 Methicillin Resistant Staphylococcus aureus (MRSA)
Preferred
IV: Vancomycin
PO (Combination): Trimethoprim/sulphamethoxazole, Rifampicin, Fusidic Acid
Alternative
IV: Linezolid, Ceftaroline
PO: Linezolid
Comments
Methicillin (oxacillin)-resistant staphylococci are resistant to all currently available beta-lactam antimicrobial agents, with the exception of ceftaroline.
MIC tests should be performed to determine the susceptibility to vancomycin of all MRSA isolates.
Rifampicin should not be used alone for antimicrobial therapy.
1.3 Community acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA)
Preferred
IV/PO: Trimethoprim/sulfamethoxazole, Clindamycin
PO: Fusidic acid + Rifampicin
Alternative
PO: Linezolid, Doxycycline
Comments
Rifampicin should not be used alone for antimicrobial therapy.
Preferred
Enterococcus faecalis:
Ampicillin
Enterococcus faecium:
Vancomycin
Vancomycin Resistant Enterococcus:
Linezolid
Alternative
Enterococcus faecalis:
Vancomycin, Linezolid
Enterococcus faecium:
Linezolid
Comments
For Enterococcus spp., cephalosporins, aminoglycosides (except for high-level resistance testing), clindamycin and trimethoprim-sulfamethoxazole may appear active in vitro but are not effective clinically and should NOT be reported as susceptible.
Ampicillin susceptibility tests should be used to predict the activity of amoxicillin.
Ampicillin results may be used to predict susceptibility to amoxicillin/clavulanate, ampicillin/sulbactam and piperacillin/tazobactam among non-beta-lactamase-producing enterococci.
Ampicillin susceptibility can be used to predict imipenem susceptibility for Enterococcus faecalis.
Nitrofurantoin can be used for susceptible Enterococcus spp. isolated from urine.
3.1 Streptococcus pyogenes (Group A), Streptococcus agalactiae (Group B), Streptococcus dysgalactiae (Group C), Streptococcus Group G
Preferred
Penicillin, Ampicillin
Alternative
Amoxicillin/clavulanate, Ampicillin/sulbactam
Comments
--
3.2 Streptococcus pneumoniae
Preferred
Penicillin
Alternative
Amoxicillin/clavulanate, Ampicillin/sulbactam, Ceftriaxone, Cefotaxime
Comments
For non-meningitis isolates of S. pneumoniae, penicillin susceptible can predict susceptibility to:
Ampicillin (oral or parenteral), amoxicillin
Beta-lactam combination agents (amoxicillin-clavulanate, ampicillin-sulbactam)
Cephalosporins (cefuroxime, ceftriaxone, cefotaxime, cefepime, ceftaroline)
Carbapenems (ertapenem, imipenem, meropenem)
3.3 Streptococcus viridans group
Preferred
Penicillin, Amoxicillin-clavulanate, Ampicillin-sulbactam
Alternative
Ceftriaxone, Cefotaxime
Comments
The viridans group of streptococci includes the following five (5) groups, with several species within each group:
mutans group
mitis group
salivarius group
bovis group
anginosus group (previously known as S. melleri group). This group includes S. anginosus, S. intermedius and S. constellatus only
References:
M100. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute. 32nd edition. 2022.
M39. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. Clinical and Laboratory Standards Institute. 5th edition. 2022.
https://www.sanfordguide.com/ stewardsip/educational-resources/all-about-antibiotic. Resources | Antibiograms - Interpretation & Use (sanfordguide.com)